Micron initiated, Rambus downgraded: Wall Street's top analyst calls

3 weeks ago 21

The Fly

Tue, April 28, 2026 astatine 9:19 AM CDT 3 min read

The astir talked astir and marketplace moving probe calls astir Wall Street are present successful 1 place. Here are today's probe calls that investors request to know, arsenic compiled by The Fly.

Top 5 Upgrades:

Baird upgraded Old Dominion (ODFL) to Neutral from Underperform with a terms people of $229, up from $204. The steadfast has an "incrementally much constructive view" connected little than truckload tonnage and volumes.
BofA upgraded TFI International (TFII) to Buy from Neutral with a terms people of $161, up from $122. Following a logistics and truckload-led bushed successful Q1, the steadfast sees favorable proviso broadside and concern request catalysts.
Piper Sandler upgraded Organon (OGN) to Neutral from Underweight with a terms people of $14, up from $5, aft the institution entered into an statement nether which Sun Pharma volition get each outstanding shares of Organon for $14 per stock successful an all-cash transaction.
TD Securities upgraded Telus (TU) to Buy from Hold with a terms people of C$20, up from C$19. The steadfast cites valuation for the upgrade pursuing the stock's caller selloff.
Less bearish connected the name, HSBC upgraded IBM (IBM) to Hold from Reduce with a $231 terms target.

Top 5 Downgrades:

Baird downgraded Rambus (RMBS) to Neutral from Outperform with an unchanged terms people of $120. The acceleration successful x86 demand, driven by agentic AI, is affirmative for Rambus, but Baird sees the imaginable for a slowdown successful registered dual inline representation modules maturation adjacent twelvemonth owed to expanding DRAM shortages.
UBS downgraded Nucor (NUE) to Neutral from Buy with a terms people of $224, up from $190. The steadfast sees a much balanced risk/reward astatine existent stock levels.
Raymond James downgraded Compass Therapeutics (CMPX) to Market Perform from Outperform with nary terms people aft the institution disclosed endurance outcomes from COMPANION-002, the Phase 3 proceedings of tovecimig successful operation with paclitaxel for the attraction of 2nd enactment biliary tract cancer.
Truist downgraded Tronox (TROX) to Sell from Hold with a terms people of $8, down from $9. The steadfast inactive expects Tronox net to amended sequentially passim 2026, but sees imaginable for Q2 guidance to disappoint.
BNP Paribas downgraded Organon (OGN) to Neutral from Outperform with a $14 terms people aft the institution entered into an statement nether which Sun Pharma volition get each outstanding shares of Organon for $14 per stock successful an all-cash transaction.

Top 5 Initiations:

DA Davidson initiated sum of Micron (MU) with a Buy standing and $1,000 terms target. The steadfast says AI is creating a "longer-than-usual representation rhythm arsenic compute deployment and request procreation beryllium successful a affirmative feedback loop."
Alliance Global initiated sum of Opendoor Technologies (OPEN) with a Buy standing and $8 terms target. The steadfast cites the company's anticipation of achieving breakeven adjusted nett income connected a 12-month spell guardant ground by the extremity of 2026 for the Buy rating.
Barclays initiated sum of Fortis (FTS) with an Overweight standing and $62 terms target. The stock's valuation does not afloat bespeak the company's "high-multiple" ITC Holdings and Canadian businesses, the steadfast tells investors successful a probe note.
William Blair initiated sum of McKesson (MCK) with an Outperform rating. The institution has a "durable competitory moat" with specialty-led maturation upside, the steadfast tells investors successful a probe note.
William Blair initiated sum of Cardinal Health (CAH) with an Outperform rating. The steadfast says the company's pharmaceutical organisation level creates a "durable competitory moat" and supports "high-growth specialty upside."